APO Research
Talk to an analyst

APO RESEARCH · REPORT

Virus like Particle (VLP) Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Virus like Particle (VLP) Vaccines Market Analysis and Forecast 2026-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchVirus like Particle (VLP) Vaccines Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Virus like Particle (VLP) Vaccines Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Virus like Particle (VLP) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Virus like Particle (VLP) Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Virus like Particle (VLP) Vaccines Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Virus like Particle (VLP) Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Virus like Particle (VLP) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Virus like Particle (VLP) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Virus like Particle (VLP) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Virus like Particle (VLP) Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Virus like Particle (VLP) Vaccines include WuXi Biologics, Junshi Biosciences, Luye Pharma Group, Chengdu Kanghua Biological Products Co., Ltd., Shanghai Bovax Biotechnology Co., Ltd., VBI Vaccines Inc, Premas Biotech, Creative Diagnostics and Creative Biostructure, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Virus like Particle (VLP) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Virus like Particle (VLP) Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Virus like Particle (VLP) Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Virus like Particle (VLP) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Virus like Particle (VLP) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Virus like Particle (VLP) Vaccines sales, projected growth trends, production technology, application and end-user industry.

Virus like Particle (VLP) Vaccines Segment by Company

WuXi Biologics

Junshi Biosciences

Luye Pharma Group

Chengdu Kanghua Biological Products Co., Ltd.

Shanghai Bovax Biotechnology Co., Ltd.

VBI Vaccines Inc

Premas Biotech

Creative Diagnostics

Creative Biostructure

Coriolis

Charles River Laboratories

BioAgilytix

AstraZeneca Group (Icosavax)

Virus like Particle (VLP) Vaccines Segment by Type

Prophylactic Vaccine

Therapeutic Vaccine

Virus like Particle (VLP) Vaccines Segment by Application

Human Papillomavirus (HPV)

Hepatitis E Virus (HEV)

Hepatitis B Virus (HBV)

Other

Virus like Particle (VLP) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virus like Particle (VLP) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Virus like Particle (VLP) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virus like Particle (VLP) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Virus like Particle (VLP) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Virus like Particle (VLP) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Virus like Particle (VLP) Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Virus like Particle (VLP) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prophylactic Vaccine Major Manufacturers Table 3. Therapeutic Vaccine Major Manufacturers Table 4. Global Virus like Particle (VLP) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Human Papillomavirus (HPV) Major Manufacturers Table 6. Hepatitis E Virus (HEV) Major Manufacturers Table 7. Hepatitis B Virus (HBV) Major Manufacturers Table 8. Other Major Manufacturers Table 9. Virus like Particle (VLP) Vaccines Industry Trends Table 10. Virus like Particle (VLP) Vaccines Industry Drivers Table 11. Virus like Particle (VLP) Vaccines Industry Opportunities and Challenges Table 12. Virus like Particle (VLP) Vaccines Industry Restraints Table 13. Global Virus like Particle (VLP) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Virus like Particle (VLP) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Virus like Particle (VLP) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Region (2021-2026) Table 17. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Region (2027-2032) Table 18. Global Virus like Particle (VLP) Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Virus like Particle (VLP) Vaccines Sales by Region (2021-2026) & (K Units) Table 20. Global Virus like Particle (VLP) Vaccines Sales by Region (2027-2032) & (K Units) Table 21. Global Virus like Particle (VLP) Vaccines Sales Market Share by Region (2021-2026) Table 22. Global Virus like Particle (VLP) Vaccines Sales Market Share by Region (2027-2032) Table 23. Global Virus like Particle (VLP) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Virus like Particle (VLP) Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Virus like Particle (VLP) Vaccines Sales Market Share by Manufacturers (2021-2026) Table 27. Global Virus like Particle (VLP) Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Virus like Particle (VLP) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Virus like Particle (VLP) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Virus like Particle (VLP) Vaccines Manufacturers, Product Type & Application Table 31. Global Virus like Particle (VLP) Vaccines Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Virus like Particle (VLP) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Virus like Particle (VLP) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Virus like Particle (VLP) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Virus like Particle (VLP) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Type (2021-2026) Table 38. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Type (2027-2032) Table 39. Global Virus like Particle (VLP) Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Virus like Particle (VLP) Vaccines Sales by Type (2021-2026) & (K Units) Table 41. Global Virus like Particle (VLP) Vaccines Sales by Type (2027-2032) & (K Units) Table 42. Global Virus like Particle (VLP) Vaccines Sales Market Share by Type (2021-2026) Table 43. Global Virus like Particle (VLP) Vaccines Sales Market Share by Type (2027-2032) Table 44. Global Virus like Particle (VLP) Vaccines Price by Type (2021-2026) & (US$/Unit) Table 45. Global Virus like Particle (VLP) Vaccines Price by Type (2027-2032) & (US$/Unit) Table 46. Global Virus like Particle (VLP) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Virus like Particle (VLP) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Virus like Particle (VLP) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Application (2021-2026) Table 50. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Application (2027-2032) Table 51. Global Virus like Particle (VLP) Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Virus like Particle (VLP) Vaccines Sales by Application (2021-2026) & (K Units) Table 53. Global Virus like Particle (VLP) Vaccines Sales by Application (2027-2032) & (K Units) Table 54. Global Virus like Particle (VLP) Vaccines Sales Market Share by Application (2021-2026) Table 55. Global Virus like Particle (VLP) Vaccines Sales Market Share by Application (2027-2032) Table 56. Global Virus like Particle (VLP) Vaccines Price by Application (2021-2026) & (US$/Unit) Table 57. Global Virus like Particle (VLP) Vaccines Price by Application (2027-2032) & (US$/Unit) Table 58. WuXi Biologics Company Information Table 59. WuXi Biologics Business Overview Table 60. WuXi Biologics Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. WuXi Biologics Virus like Particle (VLP) Vaccines Product Portfolio Table 62. WuXi Biologics Recent Development Table 63. Junshi Biosciences Company Information Table 64. Junshi Biosciences Business Overview Table 65. Junshi Biosciences Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Junshi Biosciences Virus like Particle (VLP) Vaccines Product Portfolio Table 67. Junshi Biosciences Recent Development Table 68. Luye Pharma Group Company Information Table 69. Luye Pharma Group Business Overview Table 70. Luye Pharma Group Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Luye Pharma Group Virus like Particle (VLP) Vaccines Product Portfolio Table 72. Luye Pharma Group Recent Development Table 73. Chengdu Kanghua Biological Products Co., Ltd. Company Information Table 74. Chengdu Kanghua Biological Products Co., Ltd. Business Overview Table 75. Chengdu Kanghua Biological Products Co., Ltd. Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chengdu Kanghua Biological Products Co., Ltd. Virus like Particle (VLP) Vaccines Product Portfolio Table 77. Chengdu Kanghua Biological Products Co., Ltd. Recent Development Table 78. Shanghai Bovax Biotechnology Co., Ltd. Company Information Table 79. Shanghai Bovax Biotechnology Co., Ltd. Business Overview Table 80. Shanghai Bovax Biotechnology Co., Ltd. Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai Bovax Biotechnology Co., Ltd. Virus like Particle (VLP) Vaccines Product Portfolio Table 82. Shanghai Bovax Biotechnology Co., Ltd. Recent Development Table 83. VBI Vaccines Inc Company Information Table 84. VBI Vaccines Inc Business Overview Table 85. VBI Vaccines Inc Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. VBI Vaccines Inc Virus like Particle (VLP) Vaccines Product Portfolio Table 87. VBI Vaccines Inc Recent Development Table 88. Premas Biotech Company Information Table 89. Premas Biotech Business Overview Table 90. Premas Biotech Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Premas Biotech Virus like Particle (VLP) Vaccines Product Portfolio Table 92. Premas Biotech Recent Development Table 93. Creative Diagnostics Company Information Table 94. Creative Diagnostics Business Overview Table 95. Creative Diagnostics Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Creative Diagnostics Virus like Particle (VLP) Vaccines Product Portfolio Table 97. Creative Diagnostics Recent Development Table 98. Creative Biostructure Company Information Table 99. Creative Biostructure Business Overview Table 100. Creative Biostructure Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Creative Biostructure Virus like Particle (VLP) Vaccines Product Portfolio Table 102. Creative Biostructure Recent Development Table 103. Coriolis Company Information Table 104. Coriolis Business Overview Table 105. Coriolis Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Coriolis Virus like Particle (VLP) Vaccines Product Portfolio Table 107. Coriolis Recent Development Table 108. Charles River Laboratories Company Information Table 109. Charles River Laboratories Business Overview Table 110. Charles River Laboratories Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Charles River Laboratories Virus like Particle (VLP) Vaccines Product Portfolio Table 112. Charles River Laboratories Recent Development Table 113. BioAgilytix Company Information Table 114. BioAgilytix Business Overview Table 115. BioAgilytix Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. BioAgilytix Virus like Particle (VLP) Vaccines Product Portfolio Table 117. BioAgilytix Recent Development Table 118. AstraZeneca Group (Icosavax) Company Information Table 119. AstraZeneca Group (Icosavax) Business Overview Table 120. AstraZeneca Group (Icosavax) Virus like Particle (VLP) Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. AstraZeneca Group (Icosavax) Virus like Particle (VLP) Vaccines Product Portfolio Table 122. AstraZeneca Group (Icosavax) Recent Development Table 123. North America Virus like Particle (VLP) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Virus like Particle (VLP) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Virus like Particle (VLP) Vaccines Sales by Type (2021-2026) & (K Units) Table 126. North America Virus like Particle (VLP) Vaccines Sales by Type (2027-2032) & (K Units) Table 127. North America Virus like Particle (VLP) Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Virus like Particle (VLP) Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Virus like Particle (VLP) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Virus like Particle (VLP) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Virus like Particle (VLP) Vaccines Sales by Application (2021-2026) & (K Units) Table 132. North America Virus like Particle (VLP) Vaccines Sales by Application (2027-2032) & (K Units) Table 133. North America Virus like Particle (VLP) Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Virus like Particle (VLP) Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Virus like Particle (VLP) Vaccines Sales by Country (2021-2026) & (K Units) Table 140. North America Virus like Particle (VLP) Vaccines Sales by Country (2027-2032) & (K Units) Table 141. North America Virus like Particle (VLP) Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Virus like Particle (VLP) Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 144. Canada Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 145. Mexico Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 146. Europe Virus like Particle (VLP) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Virus like Particle (VLP) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Virus like Particle (VLP) Vaccines Sales by Type (2021-2026) & (K Units) Table 149. Europe Virus like Particle (VLP) Vaccines Sales by Type (2027-2032) & (K Units) Table 150. Europe Virus like Particle (VLP) Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Virus like Particle (VLP) Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Virus like Particle (VLP) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Virus like Particle (VLP) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Virus like Particle (VLP) Vaccines Sales by Application (2021-2026) & (K Units) Table 155. Europe Virus like Particle (VLP) Vaccines Sales by Application (2027-2032) & (K Units) Table 156. Europe Virus like Particle (VLP) Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Virus like Particle (VLP) Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Europe Virus like Particle (VLP) Vaccines Sales by Country (2021-2026) & (K Units) Table 163. Europe Virus like Particle (VLP) Vaccines Sales by Country (2027-2032) & (K Units) Table 164. Europe Virus like Particle (VLP) Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Virus like Particle (VLP) Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 167. France Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 168. U.K. Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 169. Italy Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 170. Russia Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 171. Spain Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 174. Sweden Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 175. Poland Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 176. China Virus like Particle (VLP) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 177. China Virus like Particle (VLP) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 178. China Virus like Particle (VLP) Vaccines Sales by Type (2021-2026) & (K Units) Table 179. China Virus like Particle (VLP) Vaccines Sales by Type (2027-2032) & (K Units) Table 180. China Virus like Particle (VLP) Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 181. China Virus like Particle (VLP) Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 182. China Virus like Particle (VLP) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 183. China Virus like Particle (VLP) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 184. China Virus like Particle (VLP) Vaccines Sales by Application (2021-2026) & (K Units) Table 185. China Virus like Particle (VLP) Vaccines Sales by Application (2027-2032) & (K Units) Table 186. China Virus like Particle (VLP) Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 187. China Virus like Particle (VLP) Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Virus like Particle (VLP) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Virus like Particle (VLP) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Virus like Particle (VLP) Vaccines Sales by Type (2021-2026) & (K Units) Table 191. Asia Virus like Particle (VLP) Vaccines Sales by Type (2027-2032) & (K Units) Table 192. Asia Virus like Particle (VLP) Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 193. Asia Virus like Particle (VLP) Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 194. Asia Virus like Particle (VLP) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Virus like Particle (VLP) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Virus like Particle (VLP) Vaccines Sales by Application (2021-2026) & (K Units) Table 197. Asia Virus like Particle (VLP) Vaccines Sales by Application (2027-2032) & (K Units) Table 198. Asia Virus like Particle (VLP) Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 199. Asia Virus like Particle (VLP) Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. Asia Virus like Particle (VLP) Vaccines Sales by Country (2021-2026) & (K Units) Table 205. Asia Virus like Particle (VLP) Vaccines Sales by Country (2027-2032) & (K Units) Table 206. Asia Virus like Particle (VLP) Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 207. Asia Virus like Particle (VLP) Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Japan Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 209. South Korea Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 210. India Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Australia Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Virus like Particle (VLP) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Virus like Particle (VLP) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Virus like Particle (VLP) Vaccines Sales by Type (2021-2026) & (K Units) Table 217. SAMEA Virus like Particle (VLP) Vaccines Sales by Type (2027-2032) & (K Units) Table 218. SAMEA Virus like Particle (VLP) Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 219. SAMEA Virus like Particle (VLP) Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 220. SAMEA Virus like Particle (VLP) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Virus like Particle (VLP) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Virus like Particle (VLP) Vaccines Sales by Application (2021-2026) & (K Units) Table 223. SAMEA Virus like Particle (VLP) Vaccines Sales by Application (2027-2032) & (K Units) Table 224. SAMEA Virus like Particle (VLP) Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 225. SAMEA Virus like Particle (VLP) Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 226. SAMEA Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 230. SAMEA Virus like Particle (VLP) Vaccines Sales by Country (2021-2026) & (K Units) Table 231. SAMEA Virus like Particle (VLP) Vaccines Sales by Country (2027-2032) & (K Units) Table 232. SAMEA Virus like Particle (VLP) Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 233. SAMEA Virus like Particle (VLP) Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Brazil Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 235. Argentina Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 236. Chile Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 237. Colombia Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 238. Peru Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 240. Israel Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 241. UAE Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 242. Turkey Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 243. Iran Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 244. Egypt Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Virus like Particle (VLP) Vaccines Distributors List Table 248. Virus like Particle (VLP) Vaccines Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Virus like Particle (VLP) Vaccines Image Figure 2. Global Virus like Particle (VLP) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Virus like Particle (VLP) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prophylactic Vaccine Image Figure 5. Therapeutic Vaccine Image Figure 6. Global Virus like Particle (VLP) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Virus like Particle (VLP) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Human Papillomavirus (HPV) Image Figure 9. Hepatitis E Virus (HEV) Image Figure 10. Hepatitis B Virus (HBV) Image Figure 11. Other Image Figure 12. Global Virus like Particle (VLP) Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Virus like Particle (VLP) Vaccines Revenue (2021-2032) & (US$ Million) Figure 14. Global Virus like Particle (VLP) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Region (2021-2032) Figure 17. Global Virus like Particle (VLP) Vaccines Sales (2021-2032) & (K Units) Figure 18. Global Virus like Particle (VLP) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Virus like Particle (VLP) Vaccines Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Virus like Particle (VLP) Vaccines Sales YoY (2021-2032) & (K Units) Figure 21. Europe Virus like Particle (VLP) Vaccines Sales YoY (2021-2032) & (K Units) Figure 22. China Virus like Particle (VLP) Vaccines Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Virus like Particle (VLP) Vaccines Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Virus like Particle (VLP) Vaccines Sales YoY (2021-2032) & (K Units) Figure 25. Global Virus like Particle (VLP) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Virus like Particle (VLP) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Virus like Particle (VLP) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Type (2021-2032) Figure 31. Global Virus like Particle (VLP) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Virus like Particle (VLP) Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Virus like Particle (VLP) Vaccines Sales Market Share by Type (2021-2032) Figure 34. Global Virus like Particle (VLP) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Virus like Particle (VLP) Vaccines Revenue Market Share by Application (2021-2032) Figure 37. Global Virus like Particle (VLP) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Virus like Particle (VLP) Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Virus like Particle (VLP) Vaccines Sales Market Share by Application (2021-2032) Figure 40. North America Virus like Particle (VLP) Vaccines Revenue Share by Type (2021-2032) Figure 41. North America Virus like Particle (VLP) Vaccines Sales Share by Type (2021-2032) Figure 42. North America Virus like Particle (VLP) Vaccines Revenue Share by Application (2021-2032) Figure 43. North America Virus like Particle (VLP) Vaccines Sales Share by Application (2021-2032) Figure 44. North America Virus like Particle (VLP) Vaccines Revenue Share by Country (2021-2032) Figure 45. North America Virus like Particle (VLP) Vaccines Sales Share by Country (2021-2032) Figure 46. Europe Virus like Particle (VLP) Vaccines Revenue Share by Type (2021-2032) Figure 47. Europe Virus like Particle (VLP) Vaccines Sales Share by Type (2021-2032) Figure 48. Europe Virus like Particle (VLP) Vaccines Revenue Share by Application (2021-2032) Figure 49. Europe Virus like Particle (VLP) Vaccines Sales Share by Application (2021-2032) Figure 50. Europe Virus like Particle (VLP) Vaccines Revenue Share by Country (2021-2032) Figure 51. Europe Virus like Particle (VLP) Vaccines Sales Share by Country (2021-2032) Figure 52. China Virus like Particle (VLP) Vaccines Revenue Share by Type (2021-2032) Figure 53. China Virus like Particle (VLP) Vaccines Sales Share by Type (2021-2032) Figure 54. China Virus like Particle (VLP) Vaccines Revenue Share by Application (2021-2032) Figure 55. China Virus like Particle (VLP) Vaccines Sales Share by Application (2021-2032) Figure 56. Asia Virus like Particle (VLP) Vaccines Revenue Share by Type (2021-2032) Figure 57. Asia Virus like Particle (VLP) Vaccines Sales Share by Type (2021-2032) Figure 58. Asia Virus like Particle (VLP) Vaccines Revenue Share by Application (2021-2032) Figure 59. Asia Virus like Particle (VLP) Vaccines Sales Share by Application (2021-2032) Figure 60. Asia Virus like Particle (VLP) Vaccines Revenue Share by Country (2021-2032) Figure 61. Asia Virus like Particle (VLP) Vaccines Sales Share by Country (2021-2032) Figure 62. SAMEA Virus like Particle (VLP) Vaccines Revenue Share by Type (2021-2032) Figure 63. SAMEA Virus like Particle (VLP) Vaccines Sales Share by Type (2021-2032) Figure 64. SAMEA Virus like Particle (VLP) Vaccines Revenue Share by Application (2021-2032) Figure 65. SAMEA Virus like Particle (VLP) Vaccines Sales Share by Application (2021-2032) Figure 66. SAMEA Virus like Particle (VLP) Vaccines Revenue Share by Country (2021-2032) Figure 67. SAMEA Virus like Particle (VLP) Vaccines Sales Share by Country (2021-2032) Figure 68. Virus like Particle (VLP) Vaccines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Virus like Particle (VLP) Vaccines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Prophylactic Vaccine
  • Therapeutic Vaccine
Applications
  • Human Papillomavirus (HPV)
  • Hepatitis E Virus (HEV)
  • Hepatitis B Virus (HBV)
  • Other
Companies covered
  • WuXi Biologics
  • Junshi Biosciences
  • Luye Pharma Group
  • Chengdu Kanghua Biological Products Co., Ltd.
  • Shanghai Bovax Biotechnology Co., Ltd.
  • VBI Vaccines Inc
  • Premas Biotech
  • Creative Diagnostics
  • Creative Biostructure
  • Coriolis
  • Charles River Laboratories
  • BioAgilytix
  • AstraZeneca Group (Icosavax)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Virus like Particle (VLP) Vaccines Market by Type
  3. 1.2.1 Global Virus like Particle (VLP) Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prophylactic Vaccine
  5. 1.2.3 Therapeutic Vaccine
  6. 1.3 Virus like Particle (VLP) Vaccines Market by Application
  7. 1.3.1 Global Virus like Particle (VLP) Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Human Papillomavirus (HPV)
  9. 1.3.3 Hepatitis E Virus (HEV)
  10. 1.3.4 Hepatitis B Virus (HBV)
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Virus like Particle (VLP) Vaccines Market Dynamics
  1. 2.1 Virus like Particle (VLP) Vaccines Industry Trends
  2. 2.2 Virus like Particle (VLP) Vaccines Industry Drivers
  3. 2.3 Virus like Particle (VLP) Vaccines Industry Opportunities and Challenges
  4. 2.4 Virus like Particle (VLP) Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Virus like Particle (VLP) Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Virus like Particle (VLP) Vaccines Revenue by Region
  3. 3.2.1 Global Virus like Particle (VLP) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Virus like Particle (VLP) Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Virus like Particle (VLP) Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Virus like Particle (VLP) Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Virus like Particle (VLP) Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Virus like Particle (VLP) Vaccines Sales by Region
  9. 3.4.1 Global Virus like Particle (VLP) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Virus like Particle (VLP) Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Virus like Particle (VLP) Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Virus like Particle (VLP) Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Virus like Particle (VLP) Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Virus like Particle (VLP) Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Virus like Particle (VLP) Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Virus like Particle (VLP) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Virus like Particle (VLP) Vaccines Sales by Manufacturers
  6. 4.2.1 Global Virus like Particle (VLP) Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Virus like Particle (VLP) Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Virus like Particle (VLP) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Virus like Particle (VLP) Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Virus like Particle (VLP) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Virus like Particle (VLP) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Virus like Particle (VLP) Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Virus like Particle (VLP) Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Virus like Particle (VLP) Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Virus like Particle (VLP) Vaccines Tier 1, Tier 2, and Tier 3
5 Virus like Particle (VLP) Vaccines Market by Type
  1. 5.1 Global Virus like Particle (VLP) Vaccines Revenue by Type
  2. 5.1.1 Global Virus like Particle (VLP) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Virus like Particle (VLP) Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Virus like Particle (VLP) Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Virus like Particle (VLP) Vaccines Sales by Type
  6. 5.2.1 Global Virus like Particle (VLP) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Virus like Particle (VLP) Vaccines Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Virus like Particle (VLP) Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Virus like Particle (VLP) Vaccines Price by Type
6 Virus like Particle (VLP) Vaccines Market by Application
  1. 6.1 Global Virus like Particle (VLP) Vaccines Revenue by Application
  2. 6.1.1 Global Virus like Particle (VLP) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Virus like Particle (VLP) Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Virus like Particle (VLP) Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Virus like Particle (VLP) Vaccines Sales by Application
  6. 6.2.1 Global Virus like Particle (VLP) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Virus like Particle (VLP) Vaccines Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Virus like Particle (VLP) Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Virus like Particle (VLP) Vaccines Price by Application
7 Company Profiles
  1. 7.1 WuXi Biologics
  2. 7.1.1 WuXi Biologics Company Information
  3. 7.1.2 WuXi Biologics Business Overview
  4. 7.1.3 WuXi Biologics Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 WuXi Biologics Virus like Particle (VLP) Vaccines Product Portfolio
  6. 7.1.5 WuXi Biologics Recent Developments
  7. 7.2 Junshi Biosciences
  8. 7.2.1 Junshi Biosciences Company Information
  9. 7.2.2 Junshi Biosciences Business Overview
  10. 7.2.3 Junshi Biosciences Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Junshi Biosciences Virus like Particle (VLP) Vaccines Product Portfolio
  12. 7.2.5 Junshi Biosciences Recent Developments
  13. 7.3 Luye Pharma Group
  14. 7.3.1 Luye Pharma Group Company Information
  15. 7.3.2 Luye Pharma Group Business Overview
  16. 7.3.3 Luye Pharma Group Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Luye Pharma Group Virus like Particle (VLP) Vaccines Product Portfolio
  18. 7.3.5 Luye Pharma Group Recent Developments
  19. 7.4 Chengdu Kanghua Biological Products Co., Ltd.
  20. 7.4.1 Chengdu Kanghua Biological Products Co., Ltd. Company Information
  21. 7.4.2 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
  22. 7.4.3 Chengdu Kanghua Biological Products Co., Ltd. Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Chengdu Kanghua Biological Products Co., Ltd. Virus like Particle (VLP) Vaccines Product Portfolio
  24. 7.4.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
  25. 7.5 Shanghai Bovax Biotechnology Co., Ltd.
  26. 7.5.1 Shanghai Bovax Biotechnology Co., Ltd. Company Information
  27. 7.5.2 Shanghai Bovax Biotechnology Co., Ltd. Business Overview
  28. 7.5.3 Shanghai Bovax Biotechnology Co., Ltd. Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shanghai Bovax Biotechnology Co., Ltd. Virus like Particle (VLP) Vaccines Product Portfolio
  30. 7.5.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
  31. 7.6 VBI Vaccines Inc
  32. 7.6.1 VBI Vaccines Inc Company Information
  33. 7.6.2 VBI Vaccines Inc Business Overview
  34. 7.6.3 VBI Vaccines Inc Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 VBI Vaccines Inc Virus like Particle (VLP) Vaccines Product Portfolio
  36. 7.6.5 VBI Vaccines Inc Recent Developments
  37. 7.7 Premas Biotech
  38. 7.7.1 Premas Biotech Company Information
  39. 7.7.2 Premas Biotech Business Overview
  40. 7.7.3 Premas Biotech Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Premas Biotech Virus like Particle (VLP) Vaccines Product Portfolio
  42. 7.7.5 Premas Biotech Recent Developments
  43. 7.8 Creative Diagnostics
  44. 7.8.1 Creative Diagnostics Company Information
  45. 7.8.2 Creative Diagnostics Business Overview
  46. 7.8.3 Creative Diagnostics Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Creative Diagnostics Virus like Particle (VLP) Vaccines Product Portfolio
  48. 7.8.5 Creative Diagnostics Recent Developments
  49. 7.9 Creative Biostructure
  50. 7.9.1 Creative Biostructure Company Information
  51. 7.9.2 Creative Biostructure Business Overview
  52. 7.9.3 Creative Biostructure Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Creative Biostructure Virus like Particle (VLP) Vaccines Product Portfolio
  54. 7.9.5 Creative Biostructure Recent Developments
  55. 7.10 Coriolis
  56. 7.10.1 Coriolis Company Information
  57. 7.10.2 Coriolis Business Overview
  58. 7.10.3 Coriolis Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Coriolis Virus like Particle (VLP) Vaccines Product Portfolio
  60. 7.10.5 Coriolis Recent Developments
  61. 7.11 Charles River Laboratories
  62. 7.11.1 Charles River Laboratories Company Information
  63. 7.11.2 Charles River Laboratories Business Overview
  64. 7.11.3 Charles River Laboratories Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Charles River Laboratories Virus like Particle (VLP) Vaccines Product Portfolio
  66. 7.11.5 Charles River Laboratories Recent Developments
  67. 7.12 BioAgilytix
  68. 7.12.1 BioAgilytix Company Information
  69. 7.12.2 BioAgilytix Business Overview
  70. 7.12.3 BioAgilytix Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 BioAgilytix Virus like Particle (VLP) Vaccines Product Portfolio
  72. 7.12.5 BioAgilytix Recent Developments
  73. 7.13 AstraZeneca Group (Icosavax)
  74. 7.13.1 AstraZeneca Group (Icosavax) Company Information
  75. 7.13.2 AstraZeneca Group (Icosavax) Business Overview
  76. 7.13.3 AstraZeneca Group (Icosavax) Virus like Particle (VLP) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 AstraZeneca Group (Icosavax) Virus like Particle (VLP) Vaccines Product Portfolio
  78. 7.13.5 AstraZeneca Group (Icosavax) Recent Developments
8 North America
  1. 8.1 North America Virus like Particle (VLP) Vaccines Market Size by Type
  2. 8.1.1 North America Virus like Particle (VLP) Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Virus like Particle (VLP) Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Virus like Particle (VLP) Vaccines Price by Type (2021-2032)
  5. 8.2 North America Virus like Particle (VLP) Vaccines Market Size by Application
  6. 8.2.1 North America Virus like Particle (VLP) Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Virus like Particle (VLP) Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Virus like Particle (VLP) Vaccines Price by Application (2021-2032)
  9. 8.3 North America Virus like Particle (VLP) Vaccines Market Size by Country
  10. 8.3.1 North America Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Virus like Particle (VLP) Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Virus like Particle (VLP) Vaccines Market Size by Type
  2. 9.1.1 Europe Virus like Particle (VLP) Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Virus like Particle (VLP) Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Virus like Particle (VLP) Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Virus like Particle (VLP) Vaccines Market Size by Application
  6. 9.2.1 Europe Virus like Particle (VLP) Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Virus like Particle (VLP) Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Virus like Particle (VLP) Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Virus like Particle (VLP) Vaccines Market Size by Country
  10. 9.3.1 Europe Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Virus like Particle (VLP) Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Virus like Particle (VLP) Vaccines Market Size by Type
  2. 10.1.1 China Virus like Particle (VLP) Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Virus like Particle (VLP) Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Virus like Particle (VLP) Vaccines Price by Type (2021-2032)
  5. 10.2 China Virus like Particle (VLP) Vaccines Market Size by Application
  6. 10.2.1 China Virus like Particle (VLP) Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Virus like Particle (VLP) Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Virus like Particle (VLP) Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Virus like Particle (VLP) Vaccines Market Size by Type
  2. 11.1.1 Asia Virus like Particle (VLP) Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Virus like Particle (VLP) Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Virus like Particle (VLP) Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Virus like Particle (VLP) Vaccines Market Size by Application
  6. 11.2.1 Asia Virus like Particle (VLP) Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Virus like Particle (VLP) Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Virus like Particle (VLP) Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Virus like Particle (VLP) Vaccines Market Size by Country
  10. 11.3.1 Asia Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Virus like Particle (VLP) Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Virus like Particle (VLP) Vaccines Market Size by Type
  2. 12.1.1 SAMEA Virus like Particle (VLP) Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Virus like Particle (VLP) Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Virus like Particle (VLP) Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Virus like Particle (VLP) Vaccines Market Size by Application
  6. 12.2.1 SAMEA Virus like Particle (VLP) Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Virus like Particle (VLP) Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Virus like Particle (VLP) Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Virus like Particle (VLP) Vaccines Market Size by Country
  10. 12.3.1 SAMEA Virus like Particle (VLP) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Virus like Particle (VLP) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Virus like Particle (VLP) Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Virus like Particle (VLP) Vaccines Value Chain Analysis
  2. 13.1.1 Virus like Particle (VLP) Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Virus like Particle (VLP) Vaccines Production Mode & Process
  6. 13.2 Virus like Particle (VLP) Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Virus like Particle (VLP) Vaccines Distributors
  9. 13.2.3 Virus like Particle (VLP) Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst